← Back to Search

Training for Muscle Injury

Q: Is eligibility for this research limited to those aged 30 or younger?

This trial is limited to patients aged 18-35. For those outside of this age range, there are 12 trials for minors and 53 studies available for seniors.

Q: What types of individuals are most likely to be eligible for this clinical trial?

The study requires 18 participants aged between eighteen and thirty-five who have sustained some level of muscular harm. These potential patients must also be classed as low risk by the American College of Sports Medicine, fit a specific demographic (healthy, recreationally trained young adults) and demonstrate an established commitment to resistance training for at least half a year.

Q: Could you provide an overview of the experiments that have been conducted on Training?

As of now, 79 different trials for Training are underway with 16 in their final phase. Many of these studies take place at Ribeirao Preto, Sao Paulo but there is a total of 290 clinical sites offering this medication.

Q: To what extent have people volunteered to participate in this investigation?

As of July 5th 2022, this trial is not currently recruiting. It was initially posted on November 1st 20221 and has had no recent updates. Those seeking to participate in a clinical study may want to explore the 6 trials that are presently enrolling patients with muscular damage or the 79 Training trials actively looking for participants.

Q: Are there currently any openings to enroll in this experiment?

At this time, no participants are being recruited for the trial initially posted on November 1st 2022. However, there is a plethora of other studies available; 6 trials that pertain to muscular damage and 79 concerning Training require patient recruitment.

Phase < 1

Waitlist Available

Research Sponsored by University of New Mexico

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 & 48 hours post-training

Awards & highlights

Study Summary

This trial will study the effects of CBD cream on exercise-induced muscle damage and exercise performance.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 & 48 hours post-training

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 & 48 hours post-training

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 & 48 hours post-training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in exercise performance

Change in indirect markers of muscle damage

Change in muscle soreness

Trial Design

1Treatment groups

Experimental Treatment

Group I: TrainingExperimental Treatment2 Interventions

Visit 1: sign consent form, pregnancy tests for females, resting blood pressure, height/weight, body composition, and VO2max test. Visit 2: 1-repetition maximum (RM) test and protocol familiarization. Visit 3: perform a muscle-damaging exercise protocol. Pre-exercise soreness and blood samples will be collected. After, they will perform the pre-exercise testing to assess baselines levels of power and sprint times. Upon completion, they will undergo the muscle-damaging exercise protocol. Post-exercise blood samples and soreness will be collected. The participant will then be given either placebo or CBD cream to rub into their quadriceps. Visit 4 & 5: collect blood samples and soreness scale measurements. Participants will then be given the same treatment (placebo or CBD cream) as they had on visit 3. Visit 6 will be similar to visit 3, except the participant will be given the opposite treatment (placebo or CBD cream). Visits 7 & 8 will be similar to visits 4 & 5, respectively.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cannabidiol Oil

2020

Completed Phase 4

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor

372 Previous Clinical Trials

3,528,789 Total Patients Enrolled

Fabiano Amorim, PhDStudy ChairUniversity of New Meixoco

1 Previous Clinical Trials

18 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this research limited to those aged 30 or younger?

"This trial is limited to patients aged 18-35. For those outside of this age range, there are 12 trials for minors and 53 studies available for seniors."

Answered by AI

What types of individuals are most likely to be eligible for this clinical trial?

"The study requires 18 participants aged between eighteen and thirty-five who have sustained some level of muscular harm. These potential patients must also be classed as low risk by the American College of Sports Medicine, fit a specific demographic (healthy, recreationally trained young adults) and demonstrate an established commitment to resistance training for at least half a year."

Answered by AI

Could you provide an overview of the experiments that have been conducted on Training?

"As of now, 79 different trials for Training are underway with 16 in their final phase. Many of these studies take place at Ribeirao Preto, Sao Paulo but there is a total of 290 clinical sites offering this medication."

Answered by AI

To what extent have people volunteered to participate in this investigation?

"As of July 5th 2022, this trial is not currently recruiting. It was initially posted on November 1st 20221 and has had no recent updates. Those seeking to participate in a clinical study may want to explore the 6 trials that are presently enrolling patients with muscular damage or the 79 Training trials actively looking for participants."

Answered by AI

Are there currently any openings to enroll in this experiment?

"At this time, no participants are being recruited for the trial initially posted on November 1st 2022. However, there is a plethora of other studies available; 6 trials that pertain to muscular damage and 79 concerning Training require patient recruitment."

Answered by AI